Otunctemur Alper, Ozbek Emin, Sahin Suleyman, Dursun Murat, Besiroglu Huseyin, Koklu Ismail, Erkoc Mustafa, Danis Eyyup, Bozkurt Muammer, Gurbuz Ahmet
Department of Urology, Okmeydani Training and Research Hospital, Istanbul, Turkey E-mail :
Asian Pac J Cancer Prev. 2014;15(9):3993-6. doi: 10.7314/apjcp.2014.15.9.3993.
Diabetes is a chronic disease characterized by impaired fasting blood glucose that leads to disturbances in various organs. In this study, we evaluated relationships between tumor size and grade in a population of diabetic and non-diabetic patients with renal cell carcinoma.
Between 2007-2013, in our clinic radical nephrectomy performed to 310 patients for renal tumors and pathology reported renal cell carcinoma cases were enrolled in the study. Patients with and without a history of diabetes regarding fasting glucose and HgA1c levels were evaluated during surgery for tumor size and Fuhrman grade.
Diabetes was found in 95 patients. The mean age of the patients with and without diabetes mellitus was 64.3 (40-79) and 58.4 (31-87) years, respectively. In the diabetes group 51% of patients had a tumor size over 7 cm and 54% a tumor grade over Fuhrman 3. The respective figures in the non-diabetes group were 35% and 30% (p<0.05 in both cases).
Renal cancer appears more aggressive in patients with diabetes. In this study lifestyle and risk factors with diabetes regulation were observed to be important for renal cancer patients. Multicenter studies are needed in larger series for more accurate results.
糖尿病是一种以空腹血糖受损为特征的慢性疾病,可导致多个器官功能紊乱。在本研究中,我们评估了糖尿病和非糖尿病肾细胞癌患者人群中肿瘤大小与分级之间的关系。
2007年至2013年间,在我们诊所对310例因肾肿瘤接受根治性肾切除术且病理报告为肾细胞癌的患者进行了研究。根据空腹血糖和糖化血红蛋白水平,对有和无糖尿病史的患者在手术期间评估肿瘤大小和福尔曼分级。
95例患者患有糖尿病。糖尿病患者和非糖尿病患者的平均年龄分别为64.3岁(40 - 79岁)和58.4岁(31 - 87岁)。糖尿病组中,51%的患者肿瘤大小超过7 cm,54%的患者肿瘤分级超过福尔曼3级。非糖尿病组的相应数字分别为35%和30%(两种情况均p<0.05)。
糖尿病患者的肾癌似乎更具侵袭性。在本研究中,观察到生活方式和糖尿病调控的风险因素对肾癌患者很重要。需要进行多中心、更大样本量的研究以获得更准确的结果。